NVS
Biotech

Novartis trims ‘select number’ of biomedical research roles

After several staff consolidation moves in recent weeks, Novartis is again trimming its ranks, albeit in what appears to be a more limited move.
Fraiser Kansteiner May 15, 2026 10:58am
Model Medicines

Model Meds aims to ‘discover new colors’ in drug discovery quest

May 15, 2026 9:45am
syneos-herov2-04302026png

MRD as a Decision Engine: Rethinking Oncology Trial Design

Brought to you by Syneos Health
for sale sign

Alumis pulls back from would-be rival to Amgen’s Tepezza

May 15, 2026 3:44am
Aardvark

Aardvark to dig into phase 3 data early after FDA imposes hold

May 15, 2026 1:51am
Open door symbolizing exit
Favicon Fierce Pharma

CDER chief Høeg likely exiting FDA: report

May 15, 2026 1:44pm
More News

AC Immune CEO bids adieu—Chutes & Ladders

May 15, 2026 8:30am

Signant Health buys Ametris to unite data streams in trials

May 14, 2026 1:27pm
Fierce Pharma

Biopharma rallies behind Pazdur to lead FDA. But is he willing?

May 14, 2026 11:05am

BioAge CEO's big plans for 'multi-disease impact' of NLRP3 drug

May 14, 2026 11:00am